Dewmar International BMC Inc (OTCMKTS:DEWM) Making Big Moves

In our last review of Dewmar International BMC Inc (OTCMKTS:DEWM), we highlighted some of the creative promotional marketing activities that the company was actively participating in. The Company’s efforts are paying off. On Aug 3, 2017 the Company announced that, as a result of a major marketing and sales promotion at the 2017 Essence Music Festival in conjunction with the Walmart Supplier Diversity Program, it SOLD OUT of all of its Kush Cakes premium relaxation brownies in all of its online fulfillment centers.For those readers that are not familiar with Dewmar International BMC Inc, the Company is a U.S. based, veteran-owned brand management services and diversified operating company that specializes in developing, acquiring and/or licensing new products and brands for successful launch or distribution in both national and international markets. Dewmar’s primary business strategy has been to transform high profit-margin brands traditionally reserved for niche consumer markets into more widely available general consumer brands while building a sustainable business growth model. The Company is also leveraging the explosion in the worldwide popularity of products derived from industrial hemp. The signing of the 2014 Agricultural Act (the “Farm Bill”) forecasts several strong groundbreaking opportunities for companies at the forefront of the industrial hemp and cannabidiol (CBD) industries for production and development of textiles, building materials, consumable goods, nutritional supplements and medicinal compounds.In addition to its marketing efforts, Dewmar International BMC Inc continues to expand its products and services. On Aug 1, 2017 the Company announced it entered into an Memorandum of Understanding (MOU) agreement with Mjardin Management, LLC and GHD Services, Inc to pursue turnkey cannabis related business opportunities in North America. The Memorandum of Understanding outlines an effort between the Parties to provide coordinated resources, expert knowledge, certifications, legal support, engineering, training and technology that would allow an organization seeking entry into the cannabis industry a plug-and-play solution enabling rapid set-up and speed-to-market anywhere along the logistics network from cultivator to physician and dispensary. The Company’s objective is to provide the only turnkey offering that establishes a one-stop shop for organizations wanting to enter into the cannabis market to bring the fragmented pieces together as one solution for entry, growth and expansion while maintaining product standards and consistency across the supply chain.Dewmar International BMC Inc has recently initiated the paperwork with the United States Patent and Trademark Office to secure intellectual property related to using cannabinoids to treat parkinson's disease and lung cancer. Medical Marijuana has over 100 molecules or cannabinoids within the plant that in the right combinations, or using the right delivery methods, can be used to treat both cancer to Parkinson's disease. It is Dewmar's goal to utilize the experience and the education of its CEO, Marco Moran DPh, MBA to commercialize its intellectual property assets related to marijuana, and most importantly, the precise delivery of medical marijuana and its constituents and/or byproducts to bring a new era in targeted therapeutics to improve patient care and outcomes.The lung cancer invention relates to an inhalation pharmaceutical formulation of metered and/or titrated doses of certain types of cannabinoids to treat lung cancer using either a pressurized inhaler or a dry powder inhaler. The invention also pertains to the pharmaceutically acceptable derivatives of the compounds of the invention, to processes for the preparation of these compounds, to chemical intermediates useful in preparation of these compounds, to a method of combating cancerous tumors in a mammal, and to pharmaceutical compositions containing these compounds or their derivatives. Dr. Marco Moran, CEO of Dewmar International, commented:

"Cannabinoids have the potential to be one of the most effective treatments of lung cancer ever introduced to oncologists. We have taken this medical hypothesis one step further to deliver these chemicals in a metered, controlled dose which is what medical doctors are seeking."

On July 20, 2017 Dewmar International BMC Inc announced it entered into an agreement with Smart RX Systems, Inc. ("Smart Rx") to sell and market its Smart PharmAssist Kiosk. The Smart PharmAssistTM pharmacy kiosk is the most efficient, self-dispensing tele-pharmacy kiosk in the market today that allows hospitals, clinics, pharmacies and employers with over 1,000 employees to efficiently dispense medication at a fraction of the cost of traditional pharmacy overhead.Dewmar International BMC Inc announced on Jul 17, 2017 that its Board Member, Dr. Derrick Brooks, M.D. is a contributing author to an application to assist a Louisiana company in the execution and pursuit of a contract to be named the sole operator of a Medical Marijuana Cultivation and Production Facility Operator for Southern University A&M.

DEWM stock has been on the move since our last review. It reached an intraday high of $.0176 on 7/18/17. It has since retraced down to $.0088 where it is trading now. On the last three upswings since last June, the stock achieved a new high. Financial reporting remains unchanged from our last review. Current market capitalization stands at $22.76 million, on 2.59 billion shares outstanding as of Aug. 4, 2017.We will be updating our subscribers as soon as we know more. For the latest updates on DEWM, sign up below!For the full story, check out our complete coverage on DEWM.Image courtesy of Csaba Fekete via FlickrDisclosure: We have no position in DEWM and have not been compensated for this article.